Home / Healthcare / Tooth Regeneration Market

Tooth Regeneration Market Size, Share and Analysis By Type (Enamel, Dentin, and Pulp), Age Group (Geriatric, Middle Age, and Young Adult), By End User (Hospital, Dental Clinic, and Others), and Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI106943 | Status : Upcoming

The tooth regeneration industry is being propelled by the rising prevalence of oral diseases and the rising geriatric population. Oral diseases are projected to afflict almost 3.5 billion people, according to the WHO. According to the Global Burden of Disease 2019, untreated dental caries (tooth decay) in permanent teeth is the most frequent health problem.


The tooth regeneration market is also driven by the rising prevalence of dental caries, the increasing number of dentists, and the resulting in0creased numbers of tooth loss.



  • According to the Global Burden of Disease Study 2019, caries in permanent teeth affects 2 billion people worldwide, while caries of primary teeth affects 520 million children

  • Dental caries prevalence in children ranged from 40-97 percent in Eastern Asia, 38-73.7 percent in Southern Asia, and 26.5-74.7 percent in Western Asian countries, according to a study published in Pediatric International (2019)

  • According to the American Dental Association, there will be around 201,117 dentists practicing in the United States in 2020. Dentists per 100,000 people are expected to rise from 60.7 in 2020 to 67.0 in 2040.


A revolution in stem cell research in tooth regeneration has created a massive opportunity for tooth regeneration market players. A new tooth regeneration method has just been discovered and successfully tested. Stem cells will be used to re-implant teeth in this novel procedure. The University of Illinois at Chicago has been working on developing stem-cell dental implants that can regrow teeth. The new method has only been tried on animals so far, as executing the same operation on humans would necessitate some legal and ethical changes.



  • Some of the below are clinical trials according to ClinicalTrials.gov for tooth regeneration are as follows:


























Status



Conditions



Interventions



Completed



Pulp Necrosis



Drug: Triple Antibiotic Paste



Recruiting



Regeneration



Procedure: Conventional|Procedure: PRF



Completed



Pulp Necroses



Biological: Blood clot scaffold|Biological: Blood clot scaffold combined with PRF



Impact of COVID-19 on the Tooth Regeneration Market


During the COVID-19 epidemic, dental visits were reduced, particularly during the lockdown. Patients with serious disorders that required immediate treatment primarily used dental clinics. Access to care was found to be more limited in socially disadvantaged populations.



  • According to a study published in the Journal of the American Dental Association in April 2022, total dental visits in Albert Canada in 2018, 2019, and 2020 were 5,671, 5,036, and 3,612 respectively.

  • According to a survey conducted in Canada by the Oral Health Group, the most significant impact of the pandemic on dentists' practice has been a drop in revenue.

  • The COVID-19 epidemic has left an indelible mark on the US healthcare system, including dentistry industry. When compared to the same months the previous year, dental treatments were used 75 percent less in March 2020 and 79 percent less in April 2020.


Key Insights


The report will cover the following key insights:



  • Impact analysis of drivers, restrains, and opportunities.

  • Key strategies used by major companies in the industry to gain the maximum share of the global market.

  • Identified and profiled important participants in the worldwide market.

  • Impact of COVID-19 on tooth regeneration market.


Analysis by End User


Hospital segment accounts for the largest share of the global tooth regeneration market.



  • The market's expansion is aided by the presence of a large number of hospitals throughout the region. In 2020, there was around 6,146 hospitals in the United States.

  • In 2019, there were 65.79 hospitals per million populations in Japan.


Regional Analysis



Asia Pacific accounts for the largest share of the global tooth regeneration market due to the rising prevalence of dental caries and an increasing number of dentists.



  • Dental caries affects 20–90% of 6-year-old children in Europe. Dental caries and severe periodontal disease, for example, are substantial factors in tooth loss. Around 30% of Europeans, aged 65–74 have no natural teeth, limiting their ability to function and improve their quality of life.

  • According to a research study published in the Chinese Journal of Dental Research (2019), from 1980 to 2018, the overall pooled prevalence of caries in China was 52.0 percent.


Key Players Covered


The report will include the profiles of key players such as Dentsply Sirona; Institut Straumann AG; Keystone Dental, Inc.; Zimmer Biomet; Wright Medical Group N.V.; Integra LifeSciences; CryoLife, Inc.; BioMimetic Therapeutics, Inc.; Cook Group; and among others.


Segmentation


















By Type



By Demographic



By End User



By Geography




  • Enamel

  • Dentin

  • Pulp




  • Geriatric

  • Middle Age

  • Young Adult




  • Hospital

  • Dental Clinic

  • Others




  • North America (U.S. and Canada)

  • Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)

  • Asia Pacific (China, India, Australia, and the Rest of Asia Pacific)

  • Middle East & Africa (UAE, South Africa, and the Rest of the MEA)

  • Latin America (Brazil, Mexico, and the Rest of LATAM  



Key Industry Developments



  • In January 2021, Dentsply Sirona acquired Datum Dental, Ltd. (Israel). This acquisition helps the company extend its dental regeneration product line.

  • Datum Dental's biomaterial has received CE marking in Europe and Health Canada approval. The biomaterial is intended to assist the body in the regeneration of real bone tissue following dental procedures.

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients